期刊文献+

p38蛋白激酶参与BMP9诱导的C3H10T1/2细胞成骨分化 被引量:5

p38 Kinase Participated in BMP9-induced Osteogenic Differentiation of C3H10T1/2 Mesenchynal Stem Cells
原文传递
导出
摘要 目的:初步分析丝裂原活化蛋白激酶p38在BMP9诱导间充质干细胞C3H10T1/2成骨分化过程中的作用。方法:利用BMP9重组腺病毒感染C3H10T1/2细胞,Western blot检测p38激酶总蛋白表达水平和磷酸化水平。p38的特异性抑制剂SB203580抑制p38活性或RNA干扰抑制p38表达后,分析ALP活性变化,利用茜素红S染色检测钙盐沉积,Real Time PCR检测Smad6和Smad7的mRNA表达水平,动物实验确认在RNA干扰p38蛋白激酶后,对于BMP9诱导的C3H10T1/2细胞异位成骨的影响。结果:BMP9不影响p38激酶的蛋白表达水平,但却可以促进p38激酶的磷酸化;p38抑制剂SB203580可剂量依赖性地抑制由BMP9诱导的C3H10T1/2细胞的碱性磷酸酶(alkaline phosphatase,ALP)活性,RNA干扰导致p38基因沉默同样也可抑制BMP9诱导的ALP活性,但抑制效应不及SB203580;SB203580还能够抑制BMP9诱导的C3H10T1/2细胞的钙盐沉积;BMP9的靶基因Smad6和Smad7的mRNA表达也能被SB203580所抑制;干扰p38蛋白激酶可抑制BMP9诱导的C3H10T1/2细胞在裸鼠皮下异位成骨。结论:p38蛋白激酶参与了BMP9诱导的C3H10T1/2成骨分化。 Objective:Analysis the functional role of p38 kinase in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells.Methods:C3H10T1/2 cells were infected by recombinant adenovirus expressing BMP9,then the total protein level and phosphorylated form of p38 kinase were determined by Western blot.After treatment C3H10T1/2 cells with p38 specific inhibitor SB203580 or using RNA interference to silence expression of p38,the early osteogenic marker ALP activity was detected by quantitative and staining assay,later osteogenic marker calcium deposition was determined by Alizarin Red S staining,expression level of Smad6 and Smad7 was analyzed by Real time PCR.Animal assay was carried out to confirm that whether p38 silence can result in inhibition of entopic bone formation induced by BMP9 in vivo.Results: BMP9 did not change total protein level of p38,however,BMP9 increased the phosphorylated form of p38 kinase.P38 specific inhibitor SB203580 dose-dependently decreased ALP activity induced by BMP9 of C3H10T1/2 cells.Gene silence of p38 by RNA interference also led to a reduction of ALP activity.Furthermore,SB203580 markedly inhibited calcium deposition,reduced BMP9-induced expressions of Smad6 and Smad7.Moreover,p38 gene silence was also showed to inhibit entopic bone formation induced by BMP9 in vivo.Conclusion: The p38 kianse may invovlve in BMP9 induced osteoblast commitment of C3H10T1/2 mesenchymal stem cells.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2011年第5期15-21,共7页 China Biotechnology
基金 国家自然科学基金(30800658,31071304) 重庆市科委自然科学基金(CSTC2009BB5060)资助项目
关键词 骨形态发生蛋白9 间充质干细胞 P38 成骨分化 BMP9 Mesenchymal stem cells p38 Osteogenic differentiation
  • 相关文献

参考文献17

  • 1Garcta-Gemez I, Elvira G, Zapata A G, et al. Mesenchymal stem cells: biological properties and clinical applications. Expert Opin Biol Ther, 2010, 10(10) :1453-1468.
  • 2Myers T J, Granero-Moho F, Longobardi L, et al. Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opin Biol Ther, 2010,10( 12 ) : 1663-1679.
  • 3Deng Z L, Sharff K A, Tang N, et al. Regulation of osteogenic differentiation during skeletal development. Frontiers in Biosci, 2008, 13(1) : 2001-2021.
  • 4Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem, 2010,147 (1) :35-51.
  • 5Luu H H, Song W X, Luo X J, et al. Distinct Roles of Bone Morphogenetic Proteins in Osteogenic Differentiation of Mesenchymal Stem Cells. Journal of Orthopaedic Research, 2007,25(5) : 665-677.
  • 6Ulsamer A, Ortuno M J, Ruiz S, et al. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J Biol Chem, 2008,283 (7) :3816-3826.
  • 7Xiao G, Gopalakrishnan R, Jiang D, et al. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res, 2002, 17(1) :101-110.
  • 8Chang S F, Chang T K, Peng H H, et al. BMP-4 Induction of Arrest and Differentiation of Osteoblast-Like Cells via p21CIP1 and p27KIP1 Regulation. Mol Endocrinol, 2009, 23 ( 11 ) : 1827- 1838.
  • 9Vukicevic S, Grgurevie L. BMP-6 and mesenehymal stem cell differentiation. Cytokine Growth Factor Rev, 2009, 20 ( 5-6 ) : 441-448.
  • 10Rosen V. BMP2 signaling in bone development and repair. Cytokine & Growth Factor Reviews, 2009, 20 ( 5-6 ) :475-480.

同被引文献48

  • 1周灿,赵玉蓉,贺建华,范志勇,王红权.抗菌肽PR-39的研究进展[J].湖南畜牧兽医,2007(3):3-6. 被引量:3
  • 2Myers T J, Granero- Molto F, Longobardi L, et al. Mesenchymal stem cells at the intersection of cell and gene therapy[J]. Expert Opin B iol Ther, 2010, 10(12):1663- 1679.
  • 3Garcia- Gomez I, FJvira G, Zapata AG, et al. Mesenchynml stem cells: biological properties and clinical applications [ J ]. Expert Opin Biol Ther,2010, I0(10) : 1453 - 1468.
  • 4Luther G, Wagner ER, Zhu G, et al. BMP - 9 induced osteogenic differentiation of mesenchymal stem ceils: molecular mechanism and therapeutic potential[J]. Curr Gene Ther, 2011, 11 (3) : 229 - 240.
  • 5McKay WF, Peckham SM, Badura JiM. A comprehensive clinical review of recombinant human bone morphogenefic protein - 2 ( INFUSE Bone Graft) [ J ]. Int Orthoo, 2007, 31 (6) : 729 - 734.
  • 6Aeil Y, Springer IN, Broek V, et al-. Effects of bone morphogenetic mtein-7 stimulation on osteoblasts cultured on different biomaterials [ J]. J Cell Biochem, 2002, 86(1):90-98.
  • 7Luu HH, Song WX. Luo X, et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem eells[J] .J Orthoo Res, 2007, 25(5) :665 - 677.
  • 8Cargnello M, Roux PP: Activation and Function of the MAPKs and Their Substrates, the MAPK - Activated Protein Kinases [ J ]. Microbiol Mol Biol Rev, 2011, 75( 1 ) :50 - 83.
  • 9Watanabe- Takano H, Takano K, Keduka E, et al. M- Ras is activated by bone morphogenetie protein - 2 and partieipates in osteobla.stic determination, differentiation, and tran.sdifferentiation[J]. Exo Cell Res, 2010,316(3) :477 - 490.
  • 10Phimphilai M, Zhao Z, Boules H, et al. BMP signaling is required for RUNX2 - dependent induction of the osteoblast phenot.wpe[ J ]. J Bone Miner Res, 2006, 21(4) :637 - 646.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部